PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.75%
Net income growth under 50% of BB's 28.54%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
10.57%
D&A growth well above BB's 9.13%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-9.52%
Negative yoy deferred tax while BB stands at 72.82%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
8.11%
SBC growth of 8.11% while BB is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-222.37%
Both reduce yoy usage, with BB at -316.66%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-192.16%
AR is negative yoy while BB is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
132.38%
Some yoy usage while BB is negative at -166.12%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
169.79%
Some yoy increase while BB is negative at -72.48%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-22.30%
Both yoy CFO lines are negative, with BB at -0.50%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-36.27%
Both yoy lines negative, with BB at -20.88%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
91.98%
Acquisition spending well above BB's 100.00%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
-5.34%
Negative yoy purchasing while BB stands at 0.09%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-24.17%
We reduce yoy sales while BB is 32.22%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-492.86%
Both yoy lines negative, with BB at -2097.47%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
53.52%
Investing outflow well above BB's 38.01%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
261.46%
Stock issuance far above BB's 419.44%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
-38.46%
We cut yoy buybacks while BB is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.